MedTrace Logo

Evaluation of Text or Animation-based Narrative and Non-narrative Interventions to Enhance Cancer Literacy: a Pilot Study (CLARO)

NCT06026384 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2024-09-19

No results posted yet for this study

Summary

The goal of this interventional pilot study is to test and evaluate different information materials created to heighten participants cancer literacy, cancer prevention beliefs, and subsequent intention for behavioral changes. Forty individuals, intended to cover a broad socioeconomic background, will participate in the pilot study. Based on the results of this pilot study, the information materials will be adapted for the following main study.

Conditions

  • Cancer Prevention

Interventions

OTHER

text in non-narrative form

Participants will be asked to read a text and give feedback afterwards

OTHER

text in narrative form

Participants will be asked to read a text and give feedback afterwards

OTHER

animated video in non-narrative form

Participants will be asked to watch a video and give feedback afterwards

OTHER

animated video in narrative form

Participants will be asked to watch a video and give feedback afterwards

Sponsors & Collaborators

  • University of Music, Drama, and Media Hannover

    collaborator UNKNOWN

  • German Cancer Research Center

    lead OTHER

Principal Investigators

  • Karen Steindorf, Prof. Dr. · German Cancer Research Center

  • Alexander Haussmann, Dr. · German Cancer Research Center

  • Florian Herbolsheimer, Dr. · German Cancer Research Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-27
Primary Completion
2024-04-19
Completion
2024-04-19

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06026384 on ClinicalTrials.gov